Ізраїль - іврит - Ministry of Health

novartis israel ltd - travoprost - תמיסה לעין - travoprost 0.004 %w/v - travoprost - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication.

Ізраїль - іврит - Ministry of Health

promedico ltd - gadoteric acid - תמיסה להזרקה - gadoteric acid 279.3 mg/ml ml - gadoteric acid - gadoteric acid - enhancement of contrast in magnetic resonance imaging. aencephalic and spinal pathologies: brain tumours tumours of the spine and the surrounding tissue intervertebral disk prolapse infectious diseases.abdominal pathologies: primary and secondary liver tumours. osteo-articular pathology: bone and soft tissue tumours synovial diseases.magnetic resonance imaging for angiography.

Ізраїль - іврит - Ministry of Health

promedico ltd - gadoteric acid - תמיסה להזרקה - gadoteric acid 27.932 g / 100 ml - gadoteric acid - gadoteric acid - enhancement of contrast in magnetic resonance imaging. aencephalic and spinal pathologies: brain tumours tumours of the spine and the surrounding tissue intervertebral disk prolapse infectious diseases. abdominal pathologies: primary and secondary liver tumours. osteo-articular pathology: bone and soft tissue tumours synovial diseases. magnetic resonance imaging for angiography.

Ізраїль - іврит - Ministry of Health

promedico ltd - gadoteric acid - תמיסה להזרקה - gadoteric acid 27.932 g / 100 ml - gadoteric acid - gadoteric acid - enhancement of contrast in magnetic resonance imaging. aencephalic and spinal pathologies: brain tumours tumours of the spine and the surrounding tissue intervertebral disk prolapse infectious diseases. abdominal pathologies: primary and secondary liver tumours. osteo-articular pathology: bone and soft tissue tumours synovial diseases. magnetic resonance imaging for angiography.

Ізраїль - іврит - Ministry of Health

trima israel pharmaceutical products maabarot ltd - aluminium chlorohydrate; undecenoic acid; zinc undecenoate - אבקה - undecenoic acid 3 g / 100 g; aluminium chlorohydrate 3 g / 100 g; zinc undecenoate 18 g / 100 g - other antifungals for topical use - for prophylaxis and treatment of fungal infections of the skin especially "athletes foot".

Ізраїль - іврит - Ministry of Health

tzamal bio-pharma ltd - metformin hydrochloride; pioglitazone as hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin - metformin - competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.

Ізраїль - іврит - Ministry of Health

csl behring ltd., israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - prophylaxis of rh (d) immunisation in rh (d)-negative women: anti-d immune globulin is administered for the prevention of rh (d) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. treatment is not necessary when it is assured that the child or the father are rh (d)- negative. criteria for a rhesus-incompatible pregnancy and the administration of anti-d immune globulin are : a) the mother is rh (d) -negative b) the child is either rh (d)-positive rh (d)weak - positive or its rhesus type is not known. routine antepartum prophylaxis : to prevent rh (d) immunisation due to spontaneous fetomaternal haemorrhage (fmh) during the last trimester of pregnancy. postpartum prophylaxis to prevent rh (d) immunisation of the rh (d)-negative mother following delivery of a rh (d)-positive child. complications of pregnancy: interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

Ізраїль - іврит - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Ізраїль - іврит - Ministry of Health

teva pharmaceutical industries ltd, israel - rocuronium bromide - תמיסה להזרקה - rocuronium bromide 10 mg/ml - rocuronium bromide - rocuronium bromide - rocuronium teva is indicated as and adjunct to general anaesthesia to facilitate tracheal intubation during routine and rapid sequence induction, to provide skeletal muscle relaxation during surgery. rocuronium teva is also indicated as an adjunct in the intensive care unit (icu) to facilitate tracheal intubation and mechanical ventilation.

Ізраїль - іврит - Ministry of Health

3m israel - articaine hydrochloride; epinephrine hydrochloride - תמיסה להזרקה - epinephrine hydrochloride 0.006 mg/ml; articaine hydrochloride 40 mg/ml - articaine - articaine - infiltration anesthesia and nerve-block in dentistry. ubistesin is especially indicated for routine interventions such as: uncomplicated single and serial extractions. cavity and coronal stump preparations.